Paul J. Shaughnessy, MD, medical director of adult blood and marrow transplant at the Texas Transplant Institute, discusses stem cell mobilization in patients with lymphomas.

There are a variety of chemotherapy agents available to treat patients with different types of lymphoma, and physicians can still mobilize adequate stem cells, even with the newer chemotherapy regimens being used.

Physicians should also be aware of the risk of toxicity to underlining hematopoietic stem cells and not being able to collect adequate number of stem cells.

More studies are necessary, according to Shaughnessy, to better understand if enough stem cells are being given to patients and if this will impact patients better in the future.

2019 Transplantation and Cellular Therapy Meetings

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


Transplantation and Cellular Therapy Meetings

Paul J. Shaughnessy, MD, discusses stem cell mobilization in patients with lymphomas.

Dr. Shaughnessy Discusses Stem Cell Mobilization in Lymphomas